{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:10:06Z","timestamp":1776276606019,"version":"3.50.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1016\/s0090-4295(02)01593-5","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T01:05:50Z","timestamp":1034298350000},"page":"132-138","source":"Crossref","is-referenced-by-count":207,"special_numbering":"S1","title":["Androgen receptor as a target in androgen-independent prostate cancer"],"prefix":"10.1016","volume":"60","author":[{"given":"Steven P","family":"Balk","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0090-4295(02)01593-5_BIB1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1210\/edrv-16-3-271","article-title":"Androgen receptor defects","volume":"16","author":"Quigley","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0960-0760(99)00049-7","article-title":"Mechanisms of androgen receptor activation and function","volume":"69","author":"Brinkmann","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB4","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1056\/NEJM199810083391504","article-title":"Bilateral orchiectomy with or without flutamide for metastatic prostate cancer","volume":"339","author":"Eisenberger","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0090-4295(96)00325-1","article-title":"Maximum androgen blockade in advanced prostate cancer","volume":"49","author":"Caubet","year":"1997","journal-title":"Urology"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB6","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1200\/JCO.1997.15.8.2928","article-title":"Bicalutamide for advanced prostate cancer","volume":"15","author":"Scher","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-5347(01)64039-4","article-title":"High dose bicalutamide for androgen independent prostate cancer","volume":"159","author":"Joyce","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0889-8588(05)70363-4","article-title":"Treatment of metastatic prostate cancer. Lessons from the androgen receptor","volume":"10","author":"Bubley","year":"1996","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/35094009","article-title":"The development of androgen-independent prostate cancer","volume":"1","author":"Feldman","year":"2001","journal-title":"Nature Rev Cancer"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ijc.2910480206","article-title":"Androgen receptors in endocrine-therapy-resistant human prostate cancer","volume":"48","author":"van der Kwast","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB11","first-page":"735","article-title":"Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer","volume":"144","author":"Ruizeveld de Winter","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB12","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJM199505253322101","article-title":"Mutation of the androgen-receptor gene in metastatic androgen- independent prostate cancer","volume":"332","author":"Taplin","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB13","first-page":"3068","article-title":"Distant metastases from prostatic carcinoma express androgen receptor protein","volume":"55","author":"Hobisch","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/1097-0045(199609)29:3<137::AID-PROS2990290302>3.0.CO;2-Z","article-title":"Androgen receptor expression in prostatic dysplasia (prostatic intraepithelial neoplasia) in the human prostate","volume":"29","author":"Leav","year":"1996","journal-title":"Prostate"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB15","first-page":"35","article-title":"Biologic markers in prostatic intraepithelial neoplasia","volume":"46","author":"Tsuji","year":"1999","journal-title":"J Med Invest"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1096-9896(1998100)186:2<169::AID-PATH164>3.0.CO;2-W","article-title":"Expression of androgen receptor and growth factors in premalignant lesions of the prostate","volume":"186","author":"Harper","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB17","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0022-5347(01)61644-6","article-title":"Androgen receptor expression in prostatic intraepithelial neoplasia and cancer","volume":"161","author":"Sweat","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng0495-401","article-title":"In vivo amplification of the androgen receptor gene and progression of human prostate cancer","volume":"9","author":"Visakorpi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB19","first-page":"314","article-title":"Androgen receptor gene amplification","volume":"57","author":"Koivisto","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB20","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/S0022-5347(05)66935-2","article-title":"Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer","volume":"164","author":"Palmberg","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB21","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1210\/mend-5-10-1396","article-title":"Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization","volume":"5","author":"Jenster","year":"1991","journal-title":"Mol Endocrinol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0021-9258(18)52466-2","article-title":"Transcriptional activation and nuclear targeting signals of the human androgen receptor","volume":"266","author":"Simental","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB23","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1210\/me.7.12.1541","article-title":"Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone","volume":"7","author":"Culig","year":"1993","journal-title":"Mol Endocrinol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0960-0760(93)90316-O","article-title":"Androgen receptor gene mutations in human prostate cancer","volume":"46","author":"Suzuki","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/1097-0045(199609)29:3<153::AID-PROS2990290303>3.0.CO;2-5","article-title":"Codon 877 mutation in the androgen receptor gene in advanced prostate cancer","volume":"29","author":"Suzuki","year":"1996","journal-title":"Prostate"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB26","first-page":"2511","article-title":"Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist","volume":"59","author":"Taplin","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB27","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/S0022-5347(05)68158-X","article-title":"Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a","volume":"162","author":"Zhao","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0006-291X(05)80067-1","article-title":"A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens","volume":"173","author":"Veldscholte","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB29","first-page":"1383","article-title":"Functional characterization of mutant androgen receptors from androgen-independent prostate cancer","volume":"3","author":"Fenton","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/76287","article-title":"Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor","volume":"6","author":"Zhao","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1210\/er.20.3.321","article-title":"Nuclear receptor coregulators","volume":"20","author":"McKenna","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB32","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.270.5240.1354","article-title":"Sequence and characterization of a coactivator for the steroid hormone receptor superfamily","volume":"270","author":"Onate","year":"1995","journal-title":"Science"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB33","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1002\/j.1460-2075.1996.tb00736.x","article-title":"TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors","volume":"15","author":"Voegel","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/42652","article-title":"The transcriptional co-activator p\/CIP binds CBP and mediates nuclear-receptor function","volume":"387","author":"Torchia","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB35","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1128\/MCB.17.5.2735","article-title":"GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors","volume":"17","author":"Hong","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1126\/science.277.5328.965","article-title":"AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer","volume":"277","author":"Anzick","year":"1997","journal-title":"Science"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB37","doi-asserted-by":"crossref","first-page":"27629","DOI":"10.1074\/jbc.272.44.27629","article-title":"TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1","volume":"272","author":"Takeshita","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB38","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/me.12.2.302","article-title":"Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC- 1)","volume":"12","author":"Ding","year":"1998","journal-title":"Mol Endocrinol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB39","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/me.12.8.1172","article-title":"Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2)","volume":"12","author":"Berrevoets","year":"1998","journal-title":"Mol Endocrinol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB40","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1210\/me.12.10.1605","article-title":"Estrogen receptor activation function 1 works by binding p160 coactivator proteins","volume":"12","author":"Webb","year":"1998","journal-title":"Mol Endocrinol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB41","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1128\/MCB.19.9.6085","article-title":"The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription","volume":"19","author":"Alen","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB42","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.1128\/MCB.19.12.8383","article-title":"The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1","volume":"19","author":"Bevan","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB43","first-page":"4315","article-title":"A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy","volume":"61","author":"Gregory","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0090-4295(01)01117-7","article-title":"Different expression of androgen receptor coactivators in human prostate","volume":"58","author":"Fujimoto","year":"2001","journal-title":"Urology"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/377397a0","article-title":"Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor","volume":"377","author":"Horlein","year":"1995","journal-title":"Nature"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/377454a0","article-title":"A transcriptional co-repressor that interacts with nuclear hormone receptors","volume":"377","author":"Chen","year":"1995","journal-title":"Nature"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB47","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1210\/me.11.6.657","article-title":"Coactivator and corepressor regulation of the agonist\/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen","volume":"11","author":"Smith","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB48","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/39645","article-title":"Molecular basis of agonism and antagonism in the oestrogen receptor","volume":"389","author":"Brzozowski","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB49","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","article-title":"The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen","volume":"95","author":"Shiau","year":"1998","journal-title":"Cell"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB50","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1128\/MCB.21.14.4614-4625.2001","article-title":"Inhibition of androgen receptor-mediated transcription by amino-terminal enhancer of split","volume":"21","author":"Yu","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB51","doi-asserted-by":"crossref","first-page":"46647","DOI":"10.1074\/jbc.M108404200","article-title":"SRY interacts with and negatively regulates androgen receptor transcriptional activity","volume":"276","author":"Yuan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB52","series-title":"Inhibition of the dihydrotestosterone activated androgen receptor by the corepresor NCoR. Mol Endocrinol","author":"Cheng","year":"2002"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB53","first-page":"4511","article-title":"Regulation of androgen-dependent prostatic cancer cell growth","volume":"57","author":"Lu","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB54","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1210\/me.13.3.376","article-title":"Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter","volume":"13","author":"Lu","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB55","doi-asserted-by":"crossref","first-page":"20213","DOI":"10.1074\/jbc.273.32.20213","article-title":"Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells","volume":"273","author":"Knudsen","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB56","first-page":"2297","article-title":"D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability","volume":"59","author":"Knudsen","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB57","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1083\/jcb.150.4.873","article-title":"Cyclin E as a coactivator of the androgen receptor","volume":"150","author":"Yamamoto","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB58","first-page":"5718","article-title":"Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes","volume":"58","author":"Gregory","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB59","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1210\/me.15.5.765","article-title":"Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27","volume":"15","author":"Waltregny","year":"2001","journal-title":"Mol Endocrinol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB60","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1210\/me.15.5.797","article-title":"Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300\/CBP-associated factor (P\/CAF)-dependent manner","volume":"15","author":"Reutens","year":"2001","journal-title":"Mol Endocrinol"},{"issue":"suppl 2","key":"10.1016\/S0090-4295(02)01593-5_BIB61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000475232","article-title":"Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor","volume":"27","author":"Culig","year":"1995","journal-title":"Eur Urol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB62","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1210\/en.135.4.1359","article-title":"Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation","volume":"135","author":"Ikonen","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB63","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0303-7207(95)03534-E","article-title":"Synergism between androgens and protein kinase-C on androgen-regulated gene expression","volume":"110","author":"de Ruiter","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB64","doi-asserted-by":"crossref","first-page":"19900","DOI":"10.1074\/jbc.271.33.19900","article-title":"Activation of the human androgen receptor through a protein kinase A signaling pathway","volume":"271","author":"Nazareth","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB65","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1021\/bi9724422","article-title":"Forskolin-induced dephosphorylation of the androgen receptor impairs ligand binding","volume":"37","author":"Blok","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB66","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.1074\/jbc.274.12.7777","article-title":"Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways","volume":"274","author":"Sadar","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB67","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/6495","article-title":"A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2\/neu tyrosine kinase","volume":"5","author":"Craft","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB68","first-page":"4640","article-title":"Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor","volume":"58","author":"Hobisch","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB69","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/30012","article-title":"Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells","volume":"393","author":"Qiu","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB70","first-page":"2132","article-title":"Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells","volume":"60","author":"Chen","year":"2000","journal-title":"Cancer Res"},{"issue":"suppl 3","key":"10.1016\/S0090-4295(02)01593-5_BIB71","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000463972","article-title":"The pharmacokinetics of Casodex in prostate cancer patients after single and during multiple dosing","volume":"18","author":"Cockshott","year":"1990","journal-title":"Eur Urol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB72","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1128\/MCB.19.7.5143","article-title":"Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer","volume":"19","author":"Abreu-Martin","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB73","first-page":"4709","article-title":"Beta-catenin affects androgen receptor transcriptional activity and ligand specificity","volume":"60","author":"Truica","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB74","first-page":"1873","article-title":"Elevated expression of caveolin is associated with prostate and breast cancer","volume":"4","author":"Yang","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB75","doi-asserted-by":"crossref","first-page":"13442","DOI":"10.1074\/jbc.M006598200","article-title":"Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation","volume":"276","author":"Lu","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB76","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1073\/pnas.96.10.5458","article-title":"From HER2\/Neu signal cascade to androgen receptor and its coactivators","volume":"96","author":"Yeh","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/S0090-4295(02)01593-5_BIB77","doi-asserted-by":"crossref","first-page":"7200","DOI":"10.1073\/pnas.121173298","article-title":"Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor","volume":"98","author":"Lin","year":"2001","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429502015935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429502015935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T22:15:39Z","timestamp":1622153739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429502015935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S0090429502015935"],"URL":"https:\/\/doi.org\/10.1016\/s0090-4295(02)01593-5","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}